Malignant Arrhythmic Mitral Valve Prolapse: A Continuum of Clinical Challenges from Diagnosis to Risk Stratification and Patient Management

Mitral valve prolapse (MVP) is a common valvular disease, which may remain a benign condition for a long period of time. However, some patients experience malignant ventricular arrhythmias and sudden cardiac death (SCD). It is still largely unknown how to risk-stratify these patients, and no specifi...

Full description

Bibliographic Details
Main Authors: Idit Yedidya, Aniek L. van Wijngaarden, Nina Ajmone Marsan
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Series:Journal of Cardiovascular Development and Disease
Subjects:
Online Access:https://www.mdpi.com/2308-3425/8/1/2
id doaj-f1030a5e734d4e37af2a45052d102cbe
record_format Article
spelling doaj-f1030a5e734d4e37af2a45052d102cbe2020-12-30T00:00:35ZengMDPI AGJournal of Cardiovascular Development and Disease2308-34252021-12-0182210.3390/jcdd8010002Malignant Arrhythmic Mitral Valve Prolapse: A Continuum of Clinical Challenges from Diagnosis to Risk Stratification and Patient ManagementIdit Yedidya0Aniek L. van Wijngaarden1Nina Ajmone Marsan2Department of Cardiology, Leiden University Medical Center, Leiden, 2300RC Zuid-Holland, The NetherlandsDepartment of Cardiology, Leiden University Medical Center, Leiden, 2300RC Zuid-Holland, The NetherlandsDepartment of Cardiology, Leiden University Medical Center, Leiden, 2300RC Zuid-Holland, The NetherlandsMitral valve prolapse (MVP) is a common valvular disease, which may remain a benign condition for a long period of time. However, some patients experience malignant ventricular arrhythmias and sudden cardiac death (SCD). It is still largely unknown how to risk-stratify these patients, and no specific recommendations have been proposed to help the clinical decision-making. We present the case of a young man whose first clinical presentation was an out-of-hospital cardiac arrest and was subsequently diagnosed with MVP. We highlighted the possible risk factors for SCD and the challenges in the clinical management of these patients.https://www.mdpi.com/2308-3425/8/1/2mitral valve prolapsesudden cardiac deathrisk factors
collection DOAJ
language English
format Article
sources DOAJ
author Idit Yedidya
Aniek L. van Wijngaarden
Nina Ajmone Marsan
spellingShingle Idit Yedidya
Aniek L. van Wijngaarden
Nina Ajmone Marsan
Malignant Arrhythmic Mitral Valve Prolapse: A Continuum of Clinical Challenges from Diagnosis to Risk Stratification and Patient Management
Journal of Cardiovascular Development and Disease
mitral valve prolapse
sudden cardiac death
risk factors
author_facet Idit Yedidya
Aniek L. van Wijngaarden
Nina Ajmone Marsan
author_sort Idit Yedidya
title Malignant Arrhythmic Mitral Valve Prolapse: A Continuum of Clinical Challenges from Diagnosis to Risk Stratification and Patient Management
title_short Malignant Arrhythmic Mitral Valve Prolapse: A Continuum of Clinical Challenges from Diagnosis to Risk Stratification and Patient Management
title_full Malignant Arrhythmic Mitral Valve Prolapse: A Continuum of Clinical Challenges from Diagnosis to Risk Stratification and Patient Management
title_fullStr Malignant Arrhythmic Mitral Valve Prolapse: A Continuum of Clinical Challenges from Diagnosis to Risk Stratification and Patient Management
title_full_unstemmed Malignant Arrhythmic Mitral Valve Prolapse: A Continuum of Clinical Challenges from Diagnosis to Risk Stratification and Patient Management
title_sort malignant arrhythmic mitral valve prolapse: a continuum of clinical challenges from diagnosis to risk stratification and patient management
publisher MDPI AG
series Journal of Cardiovascular Development and Disease
issn 2308-3425
publishDate 2021-12-01
description Mitral valve prolapse (MVP) is a common valvular disease, which may remain a benign condition for a long period of time. However, some patients experience malignant ventricular arrhythmias and sudden cardiac death (SCD). It is still largely unknown how to risk-stratify these patients, and no specific recommendations have been proposed to help the clinical decision-making. We present the case of a young man whose first clinical presentation was an out-of-hospital cardiac arrest and was subsequently diagnosed with MVP. We highlighted the possible risk factors for SCD and the challenges in the clinical management of these patients.
topic mitral valve prolapse
sudden cardiac death
risk factors
url https://www.mdpi.com/2308-3425/8/1/2
work_keys_str_mv AT idityedidya malignantarrhythmicmitralvalveprolapseacontinuumofclinicalchallengesfromdiagnosistoriskstratificationandpatientmanagement
AT anieklvanwijngaarden malignantarrhythmicmitralvalveprolapseacontinuumofclinicalchallengesfromdiagnosistoriskstratificationandpatientmanagement
AT ninaajmonemarsan malignantarrhythmicmitralvalveprolapseacontinuumofclinicalchallengesfromdiagnosistoriskstratificationandpatientmanagement
_version_ 1724367529826058240